Bliss GVS Pharma Limited has disclosed the voting results for the postal ballot conducted to seek shareholder approval for the appointment of Mr. Santosh Parab (DIN: 01622988) as a Non-Executive and Non-Independent Director of the Company.
The postal ballot notice was dated August 12, 2026, with a record date of August 14, 2026. The total number of shareholders on the record date was 46,226. The remote e-voting process was conducted through Central Depository Services (India) Limited (CDSL) from August 21, 2026, at 9:00 AM IST to September 19, 2026, at 5:00 PM IST.
Mr. Vijay Yadav, Partner of M/s. AVS & Associates, Practising Company Secretary, was appointed as the Scrutinizer for the process and submitted his report on September 22, 2026.
Voting Results Breakdown:
Total Share Capital: 10,62,43,972 shares
Total Votes Polled: 6,23,23,227 votes (58.66% of outstanding shares)
Votes in Favor: 6,04,81,459 votes (97.04% of votes polled)
Votes Against: 18,41,768 votes (2.96% of votes polled)
Category-wise Voting Details:
- Promoter and Promoter Group: Held 3,71,30,124 shares. Voted 3,24,37,024 shares (87.36% participation). 100% voted in favor (3,24,37,024 votes).
- Public Institutions: Held 1,69,39,697 shares. Voted 1,18,54,291 shares (69.98% participation). 84.47% voted in favor (1,00,13,243 votes), 15.53% voted against (18,41,048 votes).
- Public Non-Institutions: Held 5,21,74,151 shares. Voted 1,80,31,912 shares (34.56% participation). 99.99% voted in favor (1,80,31,192 votes), 0.01% voted against (720 votes).
The resolution was passed with the required majority. The scrutinizer confirmed that the e-voting process was conducted fairly and transparently, and all relevant records have been handed over to the Company Secretary for safekeeping.
The disclosure is made pursuant to Sections 108 and 110 of the Companies Act, 2013, and Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.